Company profile for GE Healthcare Life Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We’re helping life science researchers and biopharmaceutical manufacturers evolve how new therapies and precision medicines are discovered, made, and used. Our goal is to aid in providing the right treatment to the right patient in a cost-effective, efficient, and safe way – improving the quality of life for every person. GE Healthcare Life Sciences comprises: Bioprocess: Products and solutions to increase capability for c...
We’re helping life science researchers and biopharmaceutical manufacturers evolve how new therapies and precision medicines are discovered, made, and used. Our goal is to aid in providing the right treatment to the right patient in a cost-effective, efficient, and safe way – improving the quality of life for every person. GE Healthcare Life Sciences comprises: Bioprocess: Products and solutions to increase capability for cell and protein investigation, drug discovery, and large-scale manufacturing of biopharmaceuticals, Cell & Gene Therapy, Genomics & Cellular Research.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
GE Healthcare Bio-Sciences P.O. Box 643065 Pittsburgh, PA 15264-3065
Telephone
Telephone
+1 800 526 3593
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20200422005311/en

BUSINESSWIRE
22 Apr 2020
Avacta and Cytiva team up for COVID-19
Avacta and Cytiva team up for COVID-19

13 Apr 2020

// Selina McKee PHARMATIMES

http://www.pharmatimes.com/news/avacta_and_cytiva_team_up_for_covid-19_1338012

Selina McKee PHARMATIMES
13 Apr 2020

https://www.fiercebiotech.com/medtech/conversation-emmanuel-ligner-head-new-cytiva-closing-a-21-4-billion-deal-a-time-coronavirus

Conor Hale FIERCE BIOTECH
04 Apr 2020

https://www.fiercepharma.com/manufacturing/50m-cell-and-viral-vector-manufacturing-operation-backed-by-harvard

E. Palmer FIERCE PHARMA
25 Nov 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty